Neurol. praxi. 2016;17(4):228-231 | DOI: 10.36290/neu.2016.047

Management and therapy of pediatric hydrocephalus

MUDr. Petr Vacek
Neurochirurgická klinika LF UK a FN v Plzni

Pediatric hydrocephalus is a pathophysiology condition which can negatively influence the development of the child permanently. It is most commonly caused by congenital defects and by intraventricular haemorrhage at premature infants. Diagnostics and treatment vary from adult patients in some areas. That is caused by physical parameters of the child in the time of treatment and subsequent growth and development. We always try to avoid diagnostic methods which use ionizing radiation due to its negative impact on developing brain. For surgical solution we use neuroendoscopy for obstructive hydrocephalus and shunt surgery for communicating hydrocephalus. For complex hydrocephalus we use combination of both methods. In case of well-timed and adequate treatment the child suffering from hydrocephalus can develop normally.

Keywords: pediatric hydrocephalus, neuroendoscopy, shunt surgery, electromagnetic navigation

Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vacek P. Management and therapy of pediatric hydrocephalus. Neurol. praxi. 2016;17(4):228-231. doi: 10.36290/neu.2016.047.
Download citation

References

  1. Azeem SS, Origitano TC. Ventricular catheter placement with a frameless neuronavigational system: a 1-year experience. Neurosurgery 2007; 60: 243-248. Go to original source... Go to PubMed...
  2. Flannery AM, Mitchell L. Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 1: Introduction and methodology. J Neurosurg Pediatr 2014; 14(Suppl): 3-7. Go to original source... Go to PubMed...
  3. International PHVD Drug Trial Group. International randomised controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy. Lancet 1998; 352(9126): 433-440. Go to original source...
  4. Kestle JR, Drake JM, Cochrane DD, Milner R, Walker ML, Abbott R 3rd, Boop FA. Endoscopic Shunt Insertion Trial participants: Lack of benefit of endoscopic ventriculoperitoneal shunt insertion: A multicenter randomized trial. J Neurosurg 2003; 98: 284-290. Go to original source... Go to PubMed...
  5. Lipina R, Paleček T, Reguli S, Kovářová M. Death in consequence of late failure of endoscopic third ventriculostomy. Childs Nerv Syst 2007; 23(7): 815-819. Go to original source... Go to PubMed...
  6. Lipina R, Hrbáč T, Chláchula M, Krejčí T, Kunčíková M. Endoskopická ventrikulocisternostomie u dětí s předchozí implantací ventrikuloperitonealní drenáže. Cesk Slov Neurol N 2013; 76/109(2): 207-210.
  7. McGirt MJ, Leveque JC, Wellons JC 3rd, Villavicencio AT, Hopkins JS, Fuchs HE, George TM. Cerebrospinal fluid shunt survival and etiology of failures: A seven-year institutional experience. Pediatr Neurosurg 2002; 36: 248-255. Go to original source... Go to PubMed...
  8. Mixter W. Ventriculoscopy and puncture of the floor of the third ventricle. Boston Med Surg J 1923; 188: 277-278. Go to original source...
  9. Nulsen FE, Spitz EB. Treatment of hydrocephalus by direkt shunt from ventricle to jugular vain. Surgical forum 1951: 399-403. Go to PubMed...
  10. Scott MV, Fujii AM, Behrman RH, Dillon JE. Diagnostic Ionizing Radiation Exposure in Premature Patients. J Perinatol. 2014; 34(5): 392-395. Go to original source... Go to PubMed...
  11. Volpe JJ. Intracranial hemorrhage: germinal matrix-intraventricular hemorrhage. In Volpe JJ (ed). Neurology of the Newborn. Philadelphia: Saunders Elsevier 2008: 517-588. Go to original source...
  12. Wagner W, Koch D. Mechanisms of failure after endoscopic third ventriculostomy in young infants. J Neurosurg 2005; 103(Suppl 1): 43-49. Go to original source... Go to PubMed...
  13. Willis B, Javalkar V, Vannemreddy P, Caldito G, Matsuyama J, Guthikonda B, Bollam P, Nanda A. Ventricular reservoirs and ventriculoperitoneal shunts for premature infants with posthemorrhagic hydrocephalus: an institutional experience. J Neurosurg Pediatr 2009; 3(2): 94-100. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.